The Main Cause Of Accidents In The USA Is Drowsy Drivers.
Driving torpid is a chief factor in traffic accidents and deaths in the United States, federal robustness officials reported Thursday. Federal statistics state that 2,5 percent of murderous motor vehicle crashes and 2 percent of crashes with non-fatal injuries comprise drowsy driving. But, data gathering methods make it difficult to guestimate the actual number of accidents that involve drowsy drivers. In fact, some studies have estimated that between 15 percent and 33 percent of baneful crashes may involve sleepy drivers.
And deaths and injuries are more favoured in motor vehicle crashes that involve drowsy driving, the report stated. According to the gunfire by the US Centers for Disease Control and Prevention, more than 4 percent of drivers quizzed said they had driven while weary in the month before the survey. "One out of 25 people reported falling asleep while driving in the over month," said CDC epidemiologist Anne Wheaton, the report's model author. "If you think of how many cars you see every day, one out of 25 - that's a musical big number".
And those numbers may underestimate the scope of the problem. "These were people who realized they had fallen asleep while they were driving. If you tumble asleep for even a moment you may not realize it - so that's not even taking those grass roots into account".
Monday, 5 March 2018
Nuts Cause Allergies
Nuts Cause Allergies.
Women who lunch nuts during pregnancy - and who aren't allergic themselves - are less like as not to have kids with nut allergies, a new study suggests. Dr Michael Young, an ally clinical professor of pediatrics at Harvard Medical School, and colleagues unexcited data on more than 8200 children of mothers who took part in the Nurses' Health Study II. The women had reported what they ate before, during and after their pregnancies. About 300 of the children had aliment allergies. Of those, 140 were allergic to peanuts and tree nuts.
The researchers found that mothers who ate the most peanuts or tree nuts - five times a week or more - had the lowest jeopardize of their young gentleman developing an allergy to these nuts. Children of mothers who were allergic to peanuts or tree nuts, however, did not have a significantly cut risk, the examine found. The report was published online Dec 23, 2013 in the newsletter JAMA Pediatrics. The rate of US children allergic to peanuts more than tripled from 0,4 percent in 1997 to 1,4 percent in 2010, according to training poop included in the study.
Many of those with peanut allergies also are allergic to tree nuts, such as cashews, almonds and walnuts, the researchers said. "Food allergies have become epidemic," said Dr Ruchi Gupta, an colleague professor of pediatrics at the Northwestern University Feinberg School of Medicine. "Our own studies show that 8 percent of kids in the United States have a edibles allergy - that's one in 13, about two in every classroom," said Gupta, the inventor of an accompanying record editorial.
Yet why this growth is happening remains a mystery. "We do not have any evidence as to what is causing this increase in food allergy. It's some well-intentioned of genetic and environmental link". The new findings do not demonstrate or be established a cause-and-effect relationship between women eating nuts during pregnancy and lower allergy risk in their children. "The results of our bone up are not strong enough to make dietary recommendations for pregnant women.
Women who lunch nuts during pregnancy - and who aren't allergic themselves - are less like as not to have kids with nut allergies, a new study suggests. Dr Michael Young, an ally clinical professor of pediatrics at Harvard Medical School, and colleagues unexcited data on more than 8200 children of mothers who took part in the Nurses' Health Study II. The women had reported what they ate before, during and after their pregnancies. About 300 of the children had aliment allergies. Of those, 140 were allergic to peanuts and tree nuts.
The researchers found that mothers who ate the most peanuts or tree nuts - five times a week or more - had the lowest jeopardize of their young gentleman developing an allergy to these nuts. Children of mothers who were allergic to peanuts or tree nuts, however, did not have a significantly cut risk, the examine found. The report was published online Dec 23, 2013 in the newsletter JAMA Pediatrics. The rate of US children allergic to peanuts more than tripled from 0,4 percent in 1997 to 1,4 percent in 2010, according to training poop included in the study.
Many of those with peanut allergies also are allergic to tree nuts, such as cashews, almonds and walnuts, the researchers said. "Food allergies have become epidemic," said Dr Ruchi Gupta, an colleague professor of pediatrics at the Northwestern University Feinberg School of Medicine. "Our own studies show that 8 percent of kids in the United States have a edibles allergy - that's one in 13, about two in every classroom," said Gupta, the inventor of an accompanying record editorial.
Yet why this growth is happening remains a mystery. "We do not have any evidence as to what is causing this increase in food allergy. It's some well-intentioned of genetic and environmental link". The new findings do not demonstrate or be established a cause-and-effect relationship between women eating nuts during pregnancy and lower allergy risk in their children. "The results of our bone up are not strong enough to make dietary recommendations for pregnant women.
Sunday, 4 March 2018
Prevention Of Cardiovascular Diseases By Dietary Supplements
Prevention Of Cardiovascular Diseases By Dietary Supplements.
Regular doses of the dietary accessory Coenzyme Q10 digest in half the death rate of patients agony from advanced heart failure, in a randomized double-blind trial in May 2013. Researchers also reported a significant taper off in the number of hospitalizations for heart failure patients being treated with Coenzyme Q10 (CoQ10). About 14 percent of patients taking the augment suffered from a major cardiovascular event that required health centre treatment, compared with 25 percent of patients receiving placebos.
In heart failure, the nucleus becomes weak and can no longer pump enough oxygen- and nutrient-rich blood throughout the body. Patients often sustain fatigue and breathing problems as the heart enlarges and pumps faster in an effort to join the body's needs. The study is scheduled to be presented Saturday at the annual meeting of the Heart Failure Association of the European Society of Cardiology, in Lisbon, Portugal.
And "CoQ10 is the to begin medication to remodel survival in chronic heart failure since ACE inhibitors and beta blockers more than a decade ago and should be added to touchstone heart failure therapy," lead researcher Svend Aage Mortensen, a professor with the Heart Center at Copenhagen University Hospital, in Denmark, said in a sodality dope release. While randomized clinical trails are considered the "gold standard" of studies, because this redone study was presented at a medical meeting, the data and conclusions should be viewed as preliminary until published in a peer-reviewed journal.
American cardiologists greeted the reported findings with alert optimism. "This is a study that is very auspicious but requires replication in a second confirmatory trial," said Dr Gregg Fonarow, a professor of cardiology at the University of California, Los Angeles, and a spokesman for the American Heart Association. Fonarow eminent that earlier, smaller trials with Coenzyme Q10 have produced conflicting results.
And "Some studies have shown no effect, while other studies have shown some improvement, but not nearly the redoubtable effects displayed in this trial. Coenzyme Q10 occurs certainly in the body. It functions as an electron carrier in cellular mitochondria (the cell's "powerhouse") to advise convert food to energy. It also is a powerful antioxidant, and has become a dominant over-the-counter dietary supplement.
Regular doses of the dietary accessory Coenzyme Q10 digest in half the death rate of patients agony from advanced heart failure, in a randomized double-blind trial in May 2013. Researchers also reported a significant taper off in the number of hospitalizations for heart failure patients being treated with Coenzyme Q10 (CoQ10). About 14 percent of patients taking the augment suffered from a major cardiovascular event that required health centre treatment, compared with 25 percent of patients receiving placebos.
In heart failure, the nucleus becomes weak and can no longer pump enough oxygen- and nutrient-rich blood throughout the body. Patients often sustain fatigue and breathing problems as the heart enlarges and pumps faster in an effort to join the body's needs. The study is scheduled to be presented Saturday at the annual meeting of the Heart Failure Association of the European Society of Cardiology, in Lisbon, Portugal.
And "CoQ10 is the to begin medication to remodel survival in chronic heart failure since ACE inhibitors and beta blockers more than a decade ago and should be added to touchstone heart failure therapy," lead researcher Svend Aage Mortensen, a professor with the Heart Center at Copenhagen University Hospital, in Denmark, said in a sodality dope release. While randomized clinical trails are considered the "gold standard" of studies, because this redone study was presented at a medical meeting, the data and conclusions should be viewed as preliminary until published in a peer-reviewed journal.
American cardiologists greeted the reported findings with alert optimism. "This is a study that is very auspicious but requires replication in a second confirmatory trial," said Dr Gregg Fonarow, a professor of cardiology at the University of California, Los Angeles, and a spokesman for the American Heart Association. Fonarow eminent that earlier, smaller trials with Coenzyme Q10 have produced conflicting results.
And "Some studies have shown no effect, while other studies have shown some improvement, but not nearly the redoubtable effects displayed in this trial. Coenzyme Q10 occurs certainly in the body. It functions as an electron carrier in cellular mitochondria (the cell's "powerhouse") to advise convert food to energy. It also is a powerful antioxidant, and has become a dominant over-the-counter dietary supplement.
Friday, 2 March 2018
New Treatment For Migraine
New Treatment For Migraine.
The US Food and Drug Administration has approved the commencement thingamajig aimed at easing the pain of migraines preceded by aura - sensory disturbances that come about just before an attack. About a third of migraine sufferers experience auras. The Cerena Transcranial Magnetic Stimulator would be obtained through prescription, the FDA said in a asseveration released Friday Dec, 2013. Patients use both hands to hold the mark of cadency against the back of their head and press a button so that the coat of arms can release a pulse of magnetic energy. This pulse stimulates the brain's occipital cortex, which may stem or ease migraine pain.
And "Millions of people suffer from migraines, and this rejuvenated device represents a new treatment option for some patients," Christy Foreman, director of the Office of Device Evaluation in the FDA's Center for Devices and Radiological Health, said in the statement. The agency's concurrence is based on a adversity involving 201 patients who had suffered moderate-to-strong migraine with aura.
The US Food and Drug Administration has approved the commencement thingamajig aimed at easing the pain of migraines preceded by aura - sensory disturbances that come about just before an attack. About a third of migraine sufferers experience auras. The Cerena Transcranial Magnetic Stimulator would be obtained through prescription, the FDA said in a asseveration released Friday Dec, 2013. Patients use both hands to hold the mark of cadency against the back of their head and press a button so that the coat of arms can release a pulse of magnetic energy. This pulse stimulates the brain's occipital cortex, which may stem or ease migraine pain.
And "Millions of people suffer from migraines, and this rejuvenated device represents a new treatment option for some patients," Christy Foreman, director of the Office of Device Evaluation in the FDA's Center for Devices and Radiological Health, said in the statement. The agency's concurrence is based on a adversity involving 201 patients who had suffered moderate-to-strong migraine with aura.
Friday, 23 February 2018
Doctors Discovered The Cause Of Human Aggression
Doctors Discovered The Cause Of Human Aggression.
Recurrent, unprovoked blow-ups such as parkway rage may have a biological basis, according to a new study. Blood tests of relations who display the hostile outbursts that characterize a psychiatric illness known as intermittent explosive ailment show signs of inflammation, researchers say. "What we show is that inflammation markers proteins are up in these aggressive individuals," said Dr Emil Coccaro, professor and easy chair of psychiatry and behavioral neuroscience at the University of Chicago. Currently, medication and behavior psychotherapy are used to treat intermittent explosive disorder, which affects about 16 million Americans, according to the US National Institute of Mental Health.
But these methods are operational in fewer than 50 percent of cases, the cram authors noted. Coccaro now wants to experience if anti-inflammatory medicines can reduce both unwarranted aggression and inflammation in people with this disorder. Meanwhile it's consequential for those with the condition to seek treatment, rather than expect loved ones and others to be with the episodes of unwarranted hostility.
Experts began looking at inflammation and its link to aggressive behavior about a decade ago. The revitalized research, published online Dec 18, 2013 in JAMA Psychiatry, is believed to be the primary to show that two indicators of inflammation are higher in those diagnosed with the condition than in commonality with other psychiatric disorders or good mental health. The body-wide inflammation also puts these kinsfolk at risk for other medical problems, including heart attack, stroke and arthritis.
Recurrent, unprovoked blow-ups such as parkway rage may have a biological basis, according to a new study. Blood tests of relations who display the hostile outbursts that characterize a psychiatric illness known as intermittent explosive ailment show signs of inflammation, researchers say. "What we show is that inflammation markers proteins are up in these aggressive individuals," said Dr Emil Coccaro, professor and easy chair of psychiatry and behavioral neuroscience at the University of Chicago. Currently, medication and behavior psychotherapy are used to treat intermittent explosive disorder, which affects about 16 million Americans, according to the US National Institute of Mental Health.
But these methods are operational in fewer than 50 percent of cases, the cram authors noted. Coccaro now wants to experience if anti-inflammatory medicines can reduce both unwarranted aggression and inflammation in people with this disorder. Meanwhile it's consequential for those with the condition to seek treatment, rather than expect loved ones and others to be with the episodes of unwarranted hostility.
Experts began looking at inflammation and its link to aggressive behavior about a decade ago. The revitalized research, published online Dec 18, 2013 in JAMA Psychiatry, is believed to be the primary to show that two indicators of inflammation are higher in those diagnosed with the condition than in commonality with other psychiatric disorders or good mental health. The body-wide inflammation also puts these kinsfolk at risk for other medical problems, including heart attack, stroke and arthritis.
Tuesday, 20 February 2018
Us Scientists Are Studying New Virus H7N9
Us Scientists Are Studying New Virus H7N9.
The H7N9 bird flu virus does not yet have the facility to without even trying infect people, a new study indicates. The findings nullify some previous research suggesting that H7N9 poses an imminent omen of causing a global pandemic. The H7N9 virus killed several dozen people in China earlier this year. Analyses of virus samples from that outbreak suggest that H7N9 is still mainly adapted for infecting birds, not people, according to scientists at the Scripps Research Institute in La Jolla, California The scrutiny is published in the Dec 6, 2013 exit of the scrapbook Science.
The H7N9 bird flu virus does not yet have the facility to without even trying infect people, a new study indicates. The findings nullify some previous research suggesting that H7N9 poses an imminent omen of causing a global pandemic. The H7N9 virus killed several dozen people in China earlier this year. Analyses of virus samples from that outbreak suggest that H7N9 is still mainly adapted for infecting birds, not people, according to scientists at the Scripps Research Institute in La Jolla, California The scrutiny is published in the Dec 6, 2013 exit of the scrapbook Science.
Friday, 16 February 2018
For The Treatment Of Depression The Most Effective Way Is A Combination Of Antidepressants And Psychotherapy
For The Treatment Of Depression The Most Effective Way Is A Combination Of Antidepressants And Psychotherapy.
Even as fewer Americans have sought psychotherapy for their depression, antidepressant preparation rates have continued to rise in brand-new years, a inexperienced survey reveals. "This is an encouraging trend as it suggests that fewer depressed Americans are affluent without treatment," said study author Dr Mark Olfson, a professor of clinical psychiatry at Columbia University/New York State Psychiatric Institute in New York City. "At the same time, however, the forgo in psychotherapy raises the chance that many depressed patients are not receiving optimal care".
And "While way is being made in increasing the availability of depression care, a mismatch is start-off up between clinical evidence and practice," Olfson cautioned. "For many depressed adults and youth, a claque of psychotherapy and antidepressants is the most effective approach. Yet, only about one-third of treated patients take both treatments, and the proportion receiving both treatments is declining over time. Efforts should be made to increase the availability of psychotherapy for depression".
Olfson and his colleagues communication the findings in the December issue of the Archives of General Psychiatry. The authors respected that previous research indicated that depression treatment rose significantly between 1987 and 1997, from less than 1 percent to nearly 2,5 percent. Antidepressant use all depressed patients rose similarly, from just over 37 percent to more than 74 percent. At the same time, however, the portion of patients undergoing psychotherapy dropped, from about 71 percent to 60 percent.
Newer medication options (including the introduction of serotonin discerning reuptake inhibitors, or SSRIs), automated treatment guidelines, and improved screening tools accounted for the bulge in overall treatment. For the study, the researchers analyzed matter from two national surveys on depression, one conducted in 1998 and one done in 2007. In that time period, there was a unpretentious increase in outpatient treatment rates (from 2,37 per 100 kinsmen to 2,88 per 100 people), and only a nominal bump in antidepressant use.
Even as fewer Americans have sought psychotherapy for their depression, antidepressant preparation rates have continued to rise in brand-new years, a inexperienced survey reveals. "This is an encouraging trend as it suggests that fewer depressed Americans are affluent without treatment," said study author Dr Mark Olfson, a professor of clinical psychiatry at Columbia University/New York State Psychiatric Institute in New York City. "At the same time, however, the forgo in psychotherapy raises the chance that many depressed patients are not receiving optimal care".
And "While way is being made in increasing the availability of depression care, a mismatch is start-off up between clinical evidence and practice," Olfson cautioned. "For many depressed adults and youth, a claque of psychotherapy and antidepressants is the most effective approach. Yet, only about one-third of treated patients take both treatments, and the proportion receiving both treatments is declining over time. Efforts should be made to increase the availability of psychotherapy for depression".
Olfson and his colleagues communication the findings in the December issue of the Archives of General Psychiatry. The authors respected that previous research indicated that depression treatment rose significantly between 1987 and 1997, from less than 1 percent to nearly 2,5 percent. Antidepressant use all depressed patients rose similarly, from just over 37 percent to more than 74 percent. At the same time, however, the portion of patients undergoing psychotherapy dropped, from about 71 percent to 60 percent.
Newer medication options (including the introduction of serotonin discerning reuptake inhibitors, or SSRIs), automated treatment guidelines, and improved screening tools accounted for the bulge in overall treatment. For the study, the researchers analyzed matter from two national surveys on depression, one conducted in 1998 and one done in 2007. In that time period, there was a unpretentious increase in outpatient treatment rates (from 2,37 per 100 kinsmen to 2,88 per 100 people), and only a nominal bump in antidepressant use.
Thursday, 15 February 2018
Changes In Diet And Lifestyle Does Not Prevent Alzheimer's Disease
Changes In Diet And Lifestyle Does Not Prevent Alzheimer's Disease.
There is not enough exhibit to guess that improving your lifestyle can protect you against Alzheimer's disease, a remodelled review finds. A group put together by the US National Institutes of Health looked at 165 studies to accompany if lifestyle, diet, medical factors or medications, socioeconomic status, behavioral factors, environmental factors and genetics might aid prevent the mind-robbing condition. Although biological, behavioral, public and environmental factors may contribute to the delay or prevention of cognitive decline, the critique authors couldn't draw any firm conclusions about an association between modifiable risk factors and cognitive run out of gas or Alzheimer's disease.
However, one expert doesn't belive the report represents all that is known about Alzheimer's. "I found the blast to be overly pessimistic and sometimes mistaken in their conclusions, which are largely pinched from epidemiology, which is almost always inherently inconclusive," said Greg M Cole, associate director of the Alzheimer's Center at the University of California, Los Angeles.
The material problem is that everything scientists positive suggests that intervention needs to occur before cognitive deficits begin to show themselves. Unfortunately, there aren't enough clinical trials underway to discover to be definitive answers before aging Baby Boomers will begin to be ravaged by the disease. "This implies interventions that will make a note five to seven years or more to complete and cost around $50 million.
That is tolerably expensive, and not a good timeline for trial-and-error work. Not if we want to beat the clock on the Baby Boomer span bomb". The report is published in the June 15 online emanate of the Annals of Internal Medicine. The panel, chaired by Dr Martha L Daviglus, a professor of impeding medicine at the Feinberg School of Medicine at Northwestern University, found that although lifestyle factors - such as eating a Mediterranean diet, consuming omega-3 fatty acids, being physically acting and delightful in leisure activities - were associated with a lower risk of cognitive decline, the popular evidence is "too weak to justify strongly recommending them to patients".
There is not enough exhibit to guess that improving your lifestyle can protect you against Alzheimer's disease, a remodelled review finds. A group put together by the US National Institutes of Health looked at 165 studies to accompany if lifestyle, diet, medical factors or medications, socioeconomic status, behavioral factors, environmental factors and genetics might aid prevent the mind-robbing condition. Although biological, behavioral, public and environmental factors may contribute to the delay or prevention of cognitive decline, the critique authors couldn't draw any firm conclusions about an association between modifiable risk factors and cognitive run out of gas or Alzheimer's disease.
However, one expert doesn't belive the report represents all that is known about Alzheimer's. "I found the blast to be overly pessimistic and sometimes mistaken in their conclusions, which are largely pinched from epidemiology, which is almost always inherently inconclusive," said Greg M Cole, associate director of the Alzheimer's Center at the University of California, Los Angeles.
The material problem is that everything scientists positive suggests that intervention needs to occur before cognitive deficits begin to show themselves. Unfortunately, there aren't enough clinical trials underway to discover to be definitive answers before aging Baby Boomers will begin to be ravaged by the disease. "This implies interventions that will make a note five to seven years or more to complete and cost around $50 million.
That is tolerably expensive, and not a good timeline for trial-and-error work. Not if we want to beat the clock on the Baby Boomer span bomb". The report is published in the June 15 online emanate of the Annals of Internal Medicine. The panel, chaired by Dr Martha L Daviglus, a professor of impeding medicine at the Feinberg School of Medicine at Northwestern University, found that although lifestyle factors - such as eating a Mediterranean diet, consuming omega-3 fatty acids, being physically acting and delightful in leisure activities - were associated with a lower risk of cognitive decline, the popular evidence is "too weak to justify strongly recommending them to patients".
Wednesday, 14 February 2018
New Evidence On The Relationship Between Smoking And Cancer
New Evidence On The Relationship Between Smoking And Cancer.
Men who dungeon smoking after being diagnosed with cancer are more qualified to die than those who quit smoking, a uncharted study shows. The findings demonstrate that it's not too late to stop smoking after being diagnosed with cancer, researchers say. They in use data from a study conducted in China surrounded by men aged 45 to 64, starting between 1986 and 1989.
Researchers determined that more than 1600 all them had developed cancer by 2010. Of those men, 340 were nonsmokers, 545 had quit smoking before their cancer diagnosis and 747 were smokers at the heyday they were diagnosed. Among the smokers, 214 desist from after diagnosis, 336 continued to smoke occasionally and 197 continued to smoke regularly. Compared to men who did not smoke after a cancer diagnosis, those who smoked after diagnosis had a 59 percent higher gamble of termination from all causes.
Men who dungeon smoking after being diagnosed with cancer are more qualified to die than those who quit smoking, a uncharted study shows. The findings demonstrate that it's not too late to stop smoking after being diagnosed with cancer, researchers say. They in use data from a study conducted in China surrounded by men aged 45 to 64, starting between 1986 and 1989.
Researchers determined that more than 1600 all them had developed cancer by 2010. Of those men, 340 were nonsmokers, 545 had quit smoking before their cancer diagnosis and 747 were smokers at the heyday they were diagnosed. Among the smokers, 214 desist from after diagnosis, 336 continued to smoke occasionally and 197 continued to smoke regularly. Compared to men who did not smoke after a cancer diagnosis, those who smoked after diagnosis had a 59 percent higher gamble of termination from all causes.
Special Care For Elderly Pets
Special Care For Elderly Pets.
Old life-span seems to shoo-fly up on pets just as it does in people. Long before you expect it, Fido and Snowball are no longer able to bolt out the door or curvet onto the bed. But with routine visits to the vet, regular exercise and good moment control, you can help your beloved pet ward off the onset of age-related disease, one veterinary virtuoso suggests. "Aging pets are a lot like aging people with respect to diseases," Susan Nelson, a Kansas State University aid professor of clinical services, said in a university hearsay release.
Diabetes, chronic kidney disease, cancer, osteoarthritis, periodontal disease and heart condition are among the problems pets face as they grow older. "Like people, routine exams and tests can helper detect some of these problems earlier and make treatment more successful," Nelson added, making a unique reference to heartworm prevention and general vaccinations. "It's also important to task closely with your veterinarian," Nelson said, because "many pets are on more than one type of medication as they age, just in the same way as humans".
Cats between 8 and 11 years (equal to 48 to 60 in human years) are considered "senior," while those over the time of 12 fall into the category of "geriatric". For dogs it depends on weight: those under 20 pounds are considered older at 8 years, and geriatric at 11 years. Those 120 pounds and up, however, are considered ranking at 4 years and geriatric at 6 years, with a sliding age-scale applied to canines between 20 and 120 pounds.
Old life-span seems to shoo-fly up on pets just as it does in people. Long before you expect it, Fido and Snowball are no longer able to bolt out the door or curvet onto the bed. But with routine visits to the vet, regular exercise and good moment control, you can help your beloved pet ward off the onset of age-related disease, one veterinary virtuoso suggests. "Aging pets are a lot like aging people with respect to diseases," Susan Nelson, a Kansas State University aid professor of clinical services, said in a university hearsay release.
Diabetes, chronic kidney disease, cancer, osteoarthritis, periodontal disease and heart condition are among the problems pets face as they grow older. "Like people, routine exams and tests can helper detect some of these problems earlier and make treatment more successful," Nelson added, making a unique reference to heartworm prevention and general vaccinations. "It's also important to task closely with your veterinarian," Nelson said, because "many pets are on more than one type of medication as they age, just in the same way as humans".
Cats between 8 and 11 years (equal to 48 to 60 in human years) are considered "senior," while those over the time of 12 fall into the category of "geriatric". For dogs it depends on weight: those under 20 pounds are considered older at 8 years, and geriatric at 11 years. Those 120 pounds and up, however, are considered ranking at 4 years and geriatric at 6 years, with a sliding age-scale applied to canines between 20 and 120 pounds.
Subscribe to:
Posts (Atom)